JB300 is a PROTAC-based compound that serves as a highly selective degrader of Aurora A, with a DC50 of 30 nM. It is utilized in cancer research. JB300 comprises the PROTAC target protein ligand MK-5108 [pink part], E3 ligase ligand Thalidomide-O-COOH [blue part], and PROTAC Linker Boc-NH-PEG2-C2-NH2 [black part]. The conjugate of the E3 ubiquitin ligase ligand and linker is Thalidomide-O-COOH-NH2-C2-PEG2-NH-Boc.
Molecular Weight:
906.375
CAS Number:
[3038446-90-8]
Formula:
C43H45ClFN7O10S
Target:
PROTACs|||Aurora Kinase
T204223
* VAT and and shipping costs not included. Errors and price changes excepted
